Best GLP-1 Provider No Waiting Period (2026): 5 Fast-Start Routes

By the WPG Research Team · Last verified: · Published · Next re-verification: August 14, 2026

Affiliate disclosure: We may earn a commission if you sign up through our links — at no extra cost to you. Rankings reflect verified evidence and reader fit, not commission rates. We've declined to feature providers that didn't pass our criteria.

Looking only for shipping speed after approval? That's a different question — see our Best GLP-1 That Ships Fastest comparison. This page covers the whole start path: appointment, review, payment, prescription, ship — every wait point in the chain.

Best GLP-1 Provider No Waiting Period: The Fast Answer

If you searched for the best GLP-1 provider no waiting period, here's the straight answer before the scroll. Eden is the best broad cash-pay default — 100% online, no in-person visit, transparent pricing, no membership fee, with most patients receiving medication within about a week per Eden's own published timing. Yucca Health is the cleanest "don't bill me until I'm approved" path — provider review typically within 24 hours, no live appointment, and a temporary card hold only charged on approval.

The "waiting period" people search to escape isn't really about the medication. It's about insurance. Prior authorization for Wegovy and Zepbound typically takes 5–10 business days after the request is received, per Cigna's published general PA guidance — and that's when it's approved on the first submission. Add weeks for denials, step therapy, or appeals. Cash-pay telehealth skips that bureaucracy entirely.

Compounded GLP-1 medications are not FDA-approved finished products. Always confirm current eligibility, pricing, and state availability at intake.

If your priority is…

GoalStart hereWhy
Broad cash-pay default, no membership feeEden100% online, transparent pricing, no membership fee, expedited shipping after pharmacy fulfillment
No charge unless your prescription is approvedYucca HealthTemporary card hold only; charged only on provider approval; review typically within 24 hours
FDA-approved brand-name medication (Wegovy, Zepbound, Foundayo)RoCash-pay puts you under a week to first dose; insurance route runs about 2–3 weeks
Provider choice and same-day prescriptionsSesame CareSame-day prescriptions when clinically appropriate; you pick your clinician
Needle-free compounded routeSHEDPublishes lozenge route starting at $199/month

Free intake. No insurance. No membership fee. Expedited shipping after pharmacy fulfillment.

What We Actually Verified

CategoryWhat we checked
Provider review timingEach provider's official "how it works" page and FAQ, with source URLs
Live-visit requirementsState-by-state for each featured provider
Charge timingWhen your card is hit — before or after approval, including temporary holds
Shipping methodProvider-stated language (UPS, USPS, overnight, 2-Day Air)
PricingPulled from each provider's live pricing page on May 14, 2026
Regulatory statusFDA warning letter database, FDA April 2026 503B bulks list proposal, CMS Medicare GLP-1 Bridge
Insurance prior-auth timingCigna's published general PA guidance and Ro's published insurance-route timing

We re-verify every cell quarterly and spot-check monthly when a provider changes pricing or policy. The timestamp at the top of this page updates every time we re-check.

What "No Waiting Period" Actually Means in 2026

The short version: A GLP-1 provider with no waiting period removes the delays that have nothing to do with your medical care — office appointment backlogs, waiting rooms, scheduled video visits, and insurance prior authorization. It does not mean skipping medical review, pharmacy fulfillment, or safety checks. A real clinician still reviews your intake. A real pharmacy still has to dispense and ship.

There are five separate waits in a normal GLP-1 path. Most providers only remove one or two. The best no-wait providers remove most of them at once.

The 5 Waits Hiding in Your Timeline

Cash-Pay vs Insurance: The Real Time Math

Answer capsule: Cash-pay GLP-1 through async telehealth typically runs about 5 to 9 business days end-to-end in provider-stated best-case scenarios. Insurance through telehealth with prior authorization runs about 2 to 3 weeks when PA is approved on first submission. With step therapy, denial, or appeals, that grows to 4 to 12+ weeks.
RouteTypical start timeWhere the delay lives
Cash-pay async telehealth (no live visit)5–9 business daysPharmacy fulfillment + shipping
Cash-pay telehealth with required video visit7–11 business daysVideo slot + review + shipping
Insurance through telehealth (clean PA approval)~14–21 daysPrior authorization
Insurance through telehealth (step therapy or denial)4–12+ weeksAppeals, formulary exceptions
Primary care doctor + insurance4–10 weeksAppointment + PA
Bariatric or endocrine specialist6–12 weeksAppointment backlog

Source: Cigna's published general prior-authorization guidance (5–10 business days for standard requests). Ro's published cash-pay vs insurance timing ("less than a week" cash-pay; "about 2–3 weeks" insurance). Telehealth timelines pulled from each featured provider's "how it works" page.

The wait isn't the medication. The wait is the system.

Best GLP-1 Provider No Waiting Period: Ranked by the Wait Each One Removes

Five providers cleared our criteria. Each removes a different wait. Pick the one that matches your situation.

RankProviderWhat this removesProvider reviewLive visit?Card charged when?
#1Yucca HealthThe "what if I'm not approved" wait — best no-charge-until-approval pathWithin 24 hoursNo (async)Temporary hold only; charged on approval
#2EdenThe membership-fee / dose-creep wait — best broad cash-pay defaultWithin 24 hoursNo in most statesAfter approval & plan selection
#3Ro (cash-pay)The insurance prior-auth wait for FDA-approved brand-name medsWithin ~2 daysNo in most statesMembership at intake; medication after Rx
#4Sesame CareThe provider-mismatch wait — best provider-choice routeSame-day when clinically appropriateYes (video visit)Per visit + medication
#5SHEDThe needle-aversion wait — best needle-free compounded routeAfter online intake (SLA not published)NoAfter approval
Note on MEDVi: On February 20, 2026, the FDA issued a warning letter to MEDVi regarding GLP-1 marketing claims. MEDVi's async onboarding speed is competitive, but until the cited marketing claims are corrected and the FDA closes the action, we are not leading readers there. If you've used MEDVi before, our MEDVi-to-Ro switching guide walks through dose mapping and timing.

24-hour provider review. No live appointment. Orders typically ship 2–3 business days after approval via UPS 2-Day Air.

Which Provider Matches Your Situation?

If you refuse to pay until a clinician approves you, Yucca Health. If you want the broadest cash-pay default with flat-rate pricing and a real cancel-before-pharmacy window, Eden. If you want an FDA-approved brand-name medication faster than insurance allows, Ro's cash-pay route. If you want to pick your own clinician and start same-day, Sesame Care. If you can't tolerate injections, SHED.
#1No charge until approved

Yucca Health

Best for: Cash-pay shoppers who don't want to risk paying for nothing. People who want a no-live-appointment route with quick provider review.

Not for: Anyone who specifically wants FDA-approved brand-name medication, or anyone planning to use insurance.

  • A licensed provider reviews your intake within 24 hours, per Yucca's published "how it works" page.
  • No live appointment needed — review is async.
  • A temporary card hold appears during intake; you are only charged if your prescription is approved (Yucca FAQ).
  • Approved orders ship within 2–3 business days of provider approval via UPS 2-Day Air, per Yucca's terms.
  • No weekend or holiday shipments — cold-chain handling requires Monday–Friday only.
  • Pricing: as low as $146/month for new semaglutide patients on the 6-month plan; $258/month for tirzepatide on the 6-month plan.
  • Klarna, Affirm, and Afterpay accepted on 3- and 6-month plans.

Honest tradeoff:

Yucca's lowest pricing requires a 6-month commitment, and once your prescription is approved and shipped, refunds only cover billing errors or non-approval. If refund flexibility matters more than price, Eden lets you cancel before your prescription reaches the pharmacy. But if you can commit to 6 months — and most clinical guidance suggests planning for at least 12 months on GLP-1 — Yucca's "no charge unless approved" model removes the single biggest fear in cash-pay: paying upfront and getting denied.

24-hour provider review. No live appointment. Orders typically ship 2–3 business days after approval via UPS 2-Day Air.

#2Best broad cash-pay default

Eden

Best for: Anyone who wants a mainstream-feeling online program with flat-rate pricing and no membership fee. The default starting point for most readers who hit this page.

Not for: Readers chasing the absolute lowest dollar amount on a 6-month commitment (Yucca is cheaper) or readers who need FDA-approved brand-name medication only.

  • 100% online — no in-person visit required.
  • Most patients receive medication within about a week, per Eden's own published timing. Pharmacy preparation can take up to 7 business days, followed by 1–2 business days for expedited shipping.
  • Flat-rate pricing — your monthly cost does not increase as your dose goes up. That's rare in this space.
  • Pricing: first month as low as $129, then ongoing pricing on the standard compounded semaglutide plan (verify at checkout — first-month promotional pricing varies).
  • No membership fee. No insurance required. HSA/FSA eligible.
  • Both compounded and brand-name GLP-1 options on one platform.
  • You can cancel any time before your prescription reaches the pharmacy. Once it ships, the order is final.
Why most people land here: Eden splits the difference between Yucca's no-charge-until-approved model and Ro's FDA-approved brand-name access. You get fast review, flat-rate pricing, expedited shipping, and a real cancel-before-pharmacy window.

Most patients receive medication within about a week per Eden's own published timing.

#3Best FDA-approved brand without insurance wait

Ro

Best for: Anyone who specifically wants Foundayo, Wegovy, or Zepbound (FDA-approved finished products) but doesn't want to wait 2–3 weeks for insurance prior authorization. Also good if you want an insurance concierge in your back pocket.

Not for: People who want the absolute lowest cash-pay friction. Ro is slower of the cash-pay options here — but still dramatically faster than insurance for the same medications.

  • Ro's published timing: eligibility within 2 days, then "less than a week" total to first dose on cash-pay.
  • Insurance route takes about 2–3 weeks because of prior authorization — Ro's own page.
  • Ro Body membership: $39 for the first month, then $149/month ongoing — or as low as $74/month with an annual plan paid upfront.
  • Medication pricing is separate and matches LillyDirect, NovoCare, and TrumpRx for branded products.
  • Foundayo (orforglipron — first FDA-approved non-peptide oral GLP-1, cleared April 1, 2026) starts at $149/month; $199–$299 for higher doses.
  • Zepbound KwikPen: $299/month for 2.5 mg; $399 for 5 mg; $449 for 7.5–15 mg with the current manufacturer offer.
  • Zepbound pen, Wegovy pen, and Wegovy pill all available.
  • Free GLP-1 Insurance Coverage Checker on Ro's site — see what your plan covers before committing to cash-pay.
  • Ro's insurance concierge submits prior-authorization paperwork on your behalf if you decide to use coverage later.
Why Ro's cash-pay beats the insurance route for the same drugs: Insurance prior authorization typically takes 5–10 business days when approved on first submission. With a denial or step therapy, it stretches to weeks. Ro's cash-pay route gets the same FDA-approved Foundayo or Wegovy to your door before the PA paperwork would have even moved.

Ro's published timing: less than a week to first dose on cash-pay. Insurance route runs about 2–3 weeks.

#4Best provider-choice route

Sesame Care

Best for: Readers who want to pick their own clinician, want a same-day video visit, and want FDA-approved brand-name medication. Strong fit if you also have a Costco membership.

Not for: Anyone who refuses to do a video visit, or anyone who wants the lowest-friction async path.

  • Success by Sesame starts at $59/month with an annual subscription; medication priced separately.
  • Same-day prescriptions and refills when clinically appropriate, per Sesame's published service page.
  • Online video visits with a clinician of your choice.
  • Broad FDA-approved formulary: Foundayo, Wegovy injection, Wegovy pill, Ozempic, Zepbound, Mounjaro, and Saxenda.
  • Wegovy pill and Foundayo start at $149/month; Zepbound KwikPen starts at $299/month.
  • Labs included in some membership plans.
  • Costco-member pricing available on certain medications.
Why Sesame fits here: Some "no waiting period" searchers are really frustrated about provider mismatch — they couldn't find a clinician they trusted or wanted to pick someone with the right bedside manner. Sesame is the best fit for that reader because you can read provider profiles and book directly, often same-day.

Same-day prescriptions when clinically appropriate. $59/month annual plan — medication priced separately.

#5Best needle-free / lozenge route

SHED

Best for: Anyone who's been holding off on GLP-1 because of the needle, or anyone specifically searching for oral or sublingual options.

Not for: Readers who want only FDA-approved finished medication. SHED's lozenge route is a compounded formulation, not an FDA-approved oral product. (For FDA-approved oral GLP-1, that's Foundayo through Ro.)

  • 3-minute online signup.
  • 100% online — no live appointment.
  • GLP-1 lozenges and GLP-1 injections both publicly listed starting at $199/month.
  • Free shipping and support included.
  • Licensed provider review after online intake (public pages do not publish a specific review SLA — confirm at intake).

Honest note:

SHED publishes starting pricing, but plan details, formulation route, and final eligibility-specific pricing are not all upfront before intake. If pre-commitment pricing transparency matters most, Yucca and Eden publish more detail before you sign up. If your priority is access to a needle-free compounded option without delay, SHED's onboarding is clean and fast.

3-minute online signup. No live appointment. GLP-1 lozenges and injections starting at $199/month.

How We Scored Each Provider

We graded each provider against the seven friction points that actually matter for a "no waiting period" search. Max 35 points.

ProviderApptReviewInsurancePaymentFulfillmentRegulatoryStateTotal
Yucca Health555534330
Ro (cash-pay)445345430
Eden445444328
Sesame Care244335428
SHED435333225
Yucca and Ro tie at 30 because they remove different waits. Yucca removes payment risk and live-visit friction. Ro removes the insurance wait for FDA-approved brand-name drugs. Both are correct answers for the searcher who lands on this page — the right one depends on which drug you want.

What Can Still Slow You Down (Even With a Fast Provider)

Answer capsule: The most common surprise delays are state-specific live-visit requirements, weekend ship windows (most pharmacies ship Monday–Friday only to protect medication temperature integrity), incomplete intake answers, and labs ordered after the provider sees a flag in your history. A "no waiting period" provider removes office appointments and insurance bureaucracy — not every step of legitimate medical and pharmacy care.

State Law Gotchas

A handful of states require a live video visit before any compounded GLP-1 prescription can be written. Some states limit which formulations can be shipped. Specifics change by provider and state regulation, so confirm at intake. Examples to watch for:

If you're in one of these states, add 1–3 days for a video slot.

Labs

Most fast cash-pay providers (Yucca, Eden) don't require initial labs unless your intake reveals something that warrants them — kidney function concerns, diabetes management, thyroid history. If labs are ordered, expect 3–5 extra days.

Weekend Shipping

Compounded GLP-1 medications require cold-chain shipping. Most compounding pharmacies ship Monday–Friday only. A Friday afternoon approval may not ship until Monday — a 3-day weekend delay you can't argue your way out of.

Your Intake

Be complete. Be honest. Vague answers force a follow-up message that costs you a full day. Have on hand: current weight, height, BMI, current medications, allergies, any recent lab work, your state of residence.

Alaska, Hawaii, US Territories

Add 5–7 business days regardless of provider. Cold-chain shipping to remote zones takes longer.

Which No-Wait GLP-1 Providers Are Available in My State?

Answer capsule: State availability changes faster than pricing. Each provider's intake is the source of truth for the day you sign up, but Eden, Ro, and Yucca all publish broad multi-state availability. Sesame's video-visit model depends on which clinicians are licensed in your state. SHED's state list should be confirmed before payment.

What to watch for state-by-state:

The fastest way to find out for your state: start the intake. Yucca and Eden show eligibility before payment is collected. Ro confirms during onboarding. None of the five providers above charge you for finding out you're not eligible in your state.

Can You Get a GLP-1 Without Insurance Approval?

Answer capsule: Yes. GLP-1 medications require a prescription from a licensed clinician, but they do not require an insurance company's approval. Cash-pay telehealth operates entirely outside the insurance system — no prior authorization, no step therapy, no formulary check.

This is the part of the system most people don't realize until they've spent two weeks fighting their insurer. Insurance approval is bureaucratic eligibility. It's not medical eligibility. You can be a strong clinical candidate for Wegovy and still get denied coverage because your plan classified weight-loss medication as "lifestyle" rather than "medical." That denial doesn't change your medical eligibility. It just means your insurer won't pay. Cash-pay routes go around that decision.

For FDA-approved weight-management GLP-1s, labeling generally centers on adults with obesity or adults with overweight plus at least one weight-related medical condition. Individual providers may apply additional eligibility rules based on medication, state law, medical history, lab work, pregnancy status, drug interactions, and pharmacy requirements. Cash-pay does not mean skipping any of this. It means skipping the insurance company.

Are No-Wait GLP-1 Providers Safe?

Answer capsule: A no-wait GLP-1 provider can be perfectly legitimate when it uses licensed clinicians, transparent pharmacy sourcing, clear FDA-approved versus compounded labeling, and real medical screening. Red flags include guaranteed approval before review, claims that compounded medications are "the same as" FDA-approved drugs, hidden pharmacy partners, and pressure to pay before evaluation.

The Compounded vs FDA-Approved Distinction

This page does not make active-ingredient sameness claims for compounded products. The safe regulatory distinction is simple: compounded GLP-1 medications are not FDA-approved finished products, are not FDA-approved generics, and the FDA has not reviewed them for safety, effectiveness, or quality before marketing.

The FDA has specifically warned telehealth companies about misleading marketing — most commonly for claims implying compounded GLP-1 products are equivalent to FDA-approved drugs. Compounding is legal only when the pharmacy or outsourcing facility meets the applicable 503A or 503B conditions.

503A pharmacies — state-licensed compounding pharmacies that compound for individual patient prescriptions.

503B outsourcing facilities — larger compounding facilities that meet stricter FDA manufacturing standards.

In April 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. The public comment period runs through June 29, 2026. Several large compounding labs ceased production in early 2026. Provider-specific pharmacy sourcing and regulatory verification is now a required update item on any page like this — not a footnote.

Red Flag Checklist

If a provider does any of these, walk away:

Promises approval before reviewing your medical history.
Calls compounded medication "FDA-approved" or "the same as" Wegovy / Ozempic / Zepbound.
Won't name its compounding pharmacy partner.
Hides pricing until after you've handed over your information.
Buries cancellation rules.
Pressures you with countdown timers or "today only" pricing on a serious medical decision.

Our Own Rules on This Page

The FDA-Approved Brand Path — Fastest Route to Foundayo, Wegovy, or Zepbound

Answer capsule: For FDA-approved brand-name GLP-1s — Foundayo, Wegovy pill, Wegovy pen, Zepbound pen, and Zepbound KwikPen — the fastest path that doesn't involve insurance prior authorization is Ro's cash-pay route. Ro publishes "less than a week" to first dose on cash-pay, matches LillyDirect / NovoCare / TrumpRx pricing on the medication, and runs an insurance concierge if you change your mind later.

What's New in the FDA-Approved Oral Lineup

Foundayo (orforglipron)NEW Apr 2026

FDA-approved April 1, 2026 — the first FDA-approved non-peptide oral GLP-1 pill. Unlike the Wegovy pill, Foundayo doesn't require an empty stomach or specific timing. In the ATTAIN-1 trial, participants who stayed on the highest dose lost 27.3 lb / 12.4% of body weight at 72 weeks; participants on the highest dose regardless of trial completion lost 25 lb / 11.1%, versus 5.3 lb / 2.1% on placebo (per Eli Lilly's published trial data).

Wegovy pill (oral semaglutide)NEW Dec 2025

FDA-approved December 22, 2025 as the first oral GLP-1 for weight management. Novo Nordisk reports 16.6% mean weight loss in the OASIS 4 trial.

Wegovy injection

Remains the higher-efficacy semaglutide path.

Zepbound KwikPenMulti-dose pen

The newer multi-dose injection pen that delivers a full month in one device. $299/month for 2.5 mg; $399 for 5 mg; $449 for 7.5–15 mg.

Where to Get Them Fast on Cash-Pay

SourceMedicationsSpeed / notes
RoFoundayo, Wegovy pill/pen, Zepbound pen/KwikPen"Less than a week" cash-pay. $39 first month, then $149/mo (or $74/mo annual). Medication separate.
Sesame CareFull FDA-approved brand lineupSame-day prescriptions when clinically appropriate. $59/mo annual subscription. Medication separate.
LillyDirectFoundayo, Zepbound vials, Zepbound KwikPenManufacturer-direct. Free delivery for eligible patients. Best for refills or existing prescriptions.
NovoCareWegovy pill and penManufacturer-direct. Same caveat — best with an existing prescription.
Amazon PharmacyWegovy and Foundayo pills from $149/mo; injectables from $299/moSame-day delivery in ~3,000 cities (expanding to 4,500 by end of 2026).
Walgreens Weight ManagementGLP-1s from $149/mo$49 initial video visit; manufacturer savings cards applied.

Why Ro's Cash-Pay Can Be Faster Than Insurance for the Same Drugs

Insurance prior authorization for Wegovy or Zepbound:

  • • Standard: 5–10 business days
  • • Denial / step therapy / appeal: weeks to months
  • • Formulary exclusion: may never approve

Ro's cash-pay timing:

< 1 week

Same Foundayo. Same Wegovy. Same Zepbound. No insurance company in the loop.

What About the Medicare GLP-1 Bridge?

Answer capsule: CMS has now posted the Medicare GLP-1 Bridge details. Beginning July 1, 2026, eligible Medicare Part D beneficiaries can access all formulations of Foundayo, all formulations of Wegovy, and Zepbound KwikPen through the Bridge at $50 monthly access. Zepbound single-dose vials and single-dose pens are excluded.

For deeper detail, see our Medicare GLP-1 Bridge coverage guide.

HSA, FSA, and Pay-Over-Time Options

Answer capsule: Cash-pay GLP-1 through licensed telehealth is typically eligible for HSA and FSA reimbursement when prescribed for a qualifying medical condition. Several providers also accept buy-now-pay-later through Affirm, Klarna, and Afterpay on multi-month plans. None of this adds time to your start.
ProviderHSA / FSAAffirmKlarnaAfterpay
Yucca HealthEligible at checkout✓ (3/6-mo plans)✓ (3/6-mo plans)✓ (3/6-mo plans)
EdenEligible for reimbursementAvailable on some plansAvailable on some plans
RoEligible for medication; check current site
Sesame CareEligible for medical visits
SHEDCheck at checkoutAvailable

Confirm at checkout — payment-method availability changes frequently and varies by plan length.

What Real Customers Say About the Service Experience

We only include testimonials that speak to the service experience — communication, delivery, ease of intake. We do not use testimonials as evidence of medical efficacy, weight-loss results, or safety. Results vary. Always.

"It was a quick and smooth process from the questionnaire to the shipment of my treatment."

— Yucca Health customer testimonial (Yucca public site, verified May 14, 2026)

"Super easy to sign up and got my first delivery within a couple days."

— SHED customer, Trustpilot, May 12, 2026

Sesame Care's public service page states it offers same-day prescriptions and refills when clinically appropriate.

Our Methodology

Answer capsule: We scored each provider against the actual delays that matter for a "no waiting period" search: appointment friction, provider review speed, insurance friction, payment timing, fulfillment speed, regulatory clarity, and state transparency. The ranking reflects publicly available evidence on May 14, 2026 and is editorial, not medical, advice.
CategoryWhat we measureMax
Appointment frictionNo appointment / same-day visit / scheduled video5
Provider review speedSame day / within 24 hours / unclear5
Insurance frictionCash-pay clean / insurance-optional / PA-heavy5
Payment timingCharged on approval / membership upfront / unclear5
Fulfillment speedOvernight / 2-day / standard ship after pharmacy fulfillment5
Regulatory clarityClear compounded/FDA labeling / no warning-letter cloud5
State transparencyClear state availability / hidden state list5
Total35

A licensed clinician must determine whether GLP-1 therapy is appropriate for you. This page is a comparison tool — it ranks how fast you can legitimately start, not whether the medication is the right choice for your body. We re-verify every cell quarterly. Next scheduled verification: August 14, 2026.

Who Should Not Use a No-Wait GLP-1 Provider

Answer capsule: A fast online provider isn't the right path if your medical history is complicated, if you're pregnant or breastfeeding, if you have a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2 (MEN 2), if you have active pancreatitis, or if you're not sure whether GLP-1 therapy fits your overall care. In those cases, a longer in-person clinical evaluation is the safer route — even if it takes weeks.

The hard part for an impatient reader: yes, going through a primary care doctor or obesity specialist can take 6+ weeks. We're not telling you that's a feature. We're telling you the wait can be worth it when your situation has medical complexity that a fast async intake can't fully evaluate.

If your history is complicated, don't guess.

Take the 60-second GLP-1 path quiz and we'll route you to the fast provider, careful clinician, or insurance-first path that fits your situation.

Take the free 60-second GLP-1 path quiz

Frequently Asked Questions

For cash-pay telehealth with async review, many eligible adults have medication at their door in 5 to 9 business days. Insurance routes typically add 5–10 business days for prior authorization minimum, longer if there's a denial. Same-day prescription doesn't always mean same-day medication — pharmacy fulfillment and shipping take additional time even on the fastest providers.

Yes, in some cases. Sesame Care lists same-day prescriptions when clinically appropriate. Yucca and Eden can approve within 24 hours, which is functionally same- or next-business-day. The prescription itself can be issued quickly. The medication still needs to be compounded (if applicable) and shipped.

Usually, yes. Wegovy and Zepbound require prior authorization on most commercial insurance plans. Cigna's general PA guidance says decisions typically arrive within 5–10 business days after the request is received. With denial, step therapy, or appeals, the wait grows to weeks. Cash-pay routes skip the entire process.

Yes. Prior authorization is an insurance process. If you're not using insurance, there's no PA to wait on. A licensed clinician still has to evaluate you and write the prescription, but the insurance bureaucracy is not in the loop.

Eden and Yucca Health both publish 24-hour provider review windows. Ro's eligibility is within 2 days. Sesame Care offers same-day prescriptions when clinically appropriate (requires a video visit). SHED's public pages don't publish a specific review SLA.

No. "No waiting period" means the provider removes the avoidable delays — office appointments, waiting rooms, insurance bureaucracy. It does not mean skipping clinician review or pharmacy steps. If a provider promises medication without medical review, that's a red flag.

Yucca Health states no live appointment is needed. Eden runs async in most states. Ro is async in most states. Sesame Care does require a video visit — that's part of its provider-choice value.

No. Compounded GLP-1s are not FDA-approved finished products. The FDA has not reviewed individual compounded batches for safety, effectiveness, or quality before sale. Licensed compounding pharmacies (503A for individual prescriptions, 503B for batch outsourcing) operate legally under federal and state pharmacy law, but compounded products are not interchangeable with FDA-approved Wegovy, Ozempic, Zepbound, Mounjaro, or Foundayo.

Ro's cash-pay route publishes "less than a week" to first dose for all three. Sesame Care offers same-day prescriptions for the brand-name lineup. If you already have a prescription, LillyDirect (for Foundayo and Zepbound), NovoCare (for Wegovy), and Amazon Pharmacy (same-day delivery in 3,000+ cities) are the fastest refill routes.

It depends on the provider. Yucca places a temporary card hold during intake but only charges you if your prescription is approved — if you're denied, the hold releases. Eden may collect information for a card hold but typically doesn't bill until plan selection. Ro charges the first-month membership fee, separate from medication, so terms vary. Always read the refund policy before paying.

The ones featured on this page have been verified through their published clinical processes, pharmacy partnerships, and regulatory disclosures. Legitimate providers use licensed clinicians, name their pharmacy partners, run honest FDA-approved vs compounded disclosures, and have transparent cancellation policies. Sketchy providers refuse to name pharmacy partners, claim guaranteed approval, or use compounded products without proper disclosure.

Most cash-pay GLP-1 programs are eligible for HSA and FSA reimbursement when prescribed for a qualifying medical condition. Eden and Yucca both publish HSA/FSA-eligibility language. Always keep your prescription receipt and consult your benefits administrator.

The Medicare GLP-1 Bridge begins July 1, 2026 and runs through December 31, 2027. It covers all formulations of Foundayo, all formulations of Wegovy, and Zepbound KwikPen at $50 monthly access for eligible beneficiaries. Zepbound single-dose vials and single-dose pens are excluded. Before July 1, your fastest path is cash-pay telehealth — consult your tax advisor about HSA implications if you're Medicare-enrolled.

Still Not Sure Which Path Is Right for Your Situation?

You don't have to pick blind. Our 60-second matching quiz asks the questions that actually change the answer — insurance situation, medication preference, state, formulation, budget — and routes you to the right provider for your path. Most readers finish it in under a minute and leave with a clear next step.

Take our free 60-second GLP-1 path quiz

The Bottom Line

The waiting period people search to escape isn't about the medication. It's about the bureaucracy.

Pick your route. Complete the intake honestly. Many eligible cash-pay adults are on medication within about a week.

Last verified: . We'll re-check every cell on this page in August.

Related GLP-1 guides

About This Page

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We assembled this comparison by opening each provider's official "how it works," pricing, and FAQ pages on May 14, 2026 and logging every claim with a source URL. Insurance prior-authorization timelines pulled from Cigna's published general PA guidance and Ro's published insurance-route timing. Regulatory context pulled from the FDA's warning letter database, the FDA's April 2026 proposal to exclude semaglutide / tirzepatide / liraglutide from the 503B bulks list, and the CMS Medicare GLP-1 Bridge page.

By the WPG Research Team. We do not list a "medically reviewed by" credential unless an actual licensed clinician has reviewed and approved their name appearing. We don't manufacture credentials. We don't inflate review counts. We disclose every material limitation, including FDA actions on providers we'd otherwise be paid to send you to.

Sources

This page is for informational purposes and is not medical advice. GLP-1 medications have black box warnings and are not appropriate for everyone. Talk to a licensed clinician about whether GLP-1 therapy is right for your specific situation.

60-sec quiz